Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, December 17, 2016 ) The Global Cardiovascular Partnering 2010-2015 report provides an understanding and access to the cardiovascular partnering deals and agreements entered into by the worlds leading healthcare companies.
Trends in cardiovascular partnering deals Disclosed headlines, upfronts, milestones and royalties by stage of development Cardiovascular partnering contract documents Top cardiovascular deals by value
The Global Cardiovascular Partnering 2010-2015 report provides an understanding and access to the cardiovascular partnering deals and agreements entered into by the worlds leading healthcare companies.
The report provides a detailed understanding and analysis of how and why companies enter cardiovascular partnering deals. The majority of deals are development stage whereby the licensee obtains a right or an option right to license the licensors cardiovascular technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.
This report provides details of the latest cardiovascular agreements announced in the healthcare sector.
Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered – contract documents provide this insight where press releases and databases do not.
To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=303122
This report contains a comprehensive listing of all cardiovascular partnering deals announced since 2010 including financial terms where available including over 200 links to online deal records of actual cardiovascular partnering deals as disclosed by the deal parties. In addition, where available, records include contract documents as submitted to the Securities Exchange Commission by companies and their partners.
Contract documents provide the answers to numerous questions about a prospective partner’s flexibility on a wide range of important issues, many of which will have a significant impact on each party’s ability to derive value from the deal.
The initial chapters of the report provide an orientation of cardiovascular dealmaking and its associated business and partnering activities. This chapter provides an overall introduction to the report and what you will learn from it, whilst chapter 2 provides an overview of the trends in cardiovascular deal making since 2010, categorizing by deal type, industry sector, stage of development and technology type.
A popular section with readers; chapter 3 covers the average financial deal terms for deals signed in the cardiovascular field with a stage of development announced. Deals are listed and sectioned by average headlines, upfront payments, milestone payments and royalty rates. The median values of these deals are then presented by stage of development at signing.
Numerous tables and figures are weaved within the report to support the findings and illustrate the trends and activities in cardiovascular partnering and dealmaking since 2010.
Chapter 4 covers the leading cardiovascular deals that have been announced over the past five years. Deals are listed by headline value. Where the deal has an agreement contract published at the SEC a link provides online access to the contract. Full deal contract documents where available for each deal are indicated by a yes/no symbol. Within this chapter the most active cardiovascular deal makers are also listed as well as the deal making activities and the number of deals entered into by the big pharma and biotech companies.
For More Information Kindly Contact:
ResearchMoz Mr. Nachiket Ghumare, Tel: +1-518-621-2074 USA-Canada Toll Free: 866-997-4948 Email: sales@researchmoz.us Follow us on LinkedIn @ http://bit.ly/1TBmnVG
Researchmoz Global Pvt.Ltd
Researchmoz
+1-518-621-2074
sales@researchmoz.us
Source: EmailWire.Com
Source: EmailWire.com
|
|
|
|